The NanoAssemblr® Blaze™| Create Transformative Medicines


November 28, 2016

The NanoAssemblr® Blaze is enabling for researchers and drug development programs. The dynamic volume range allows researchers to use the Blaze for nanoparticle discovery, for preclinical toxicology testing, and for early Chemistry, Manufacturing and Controls (CMC) studies. The NanoAssemblr Blaze was developed to bridge the gap between nanoparticle discovery and clinical development. The Blaze can manufacture between 10 mL and 1 L per batch. Nanoparticles made on Precision NanoSystems’ Benchtop instrument scale seamlessly to the Blaze with minimum process development accelerating transfer of nanoparticle candidates towards clinical development.

Advanced Search

  • Publications
  • Application Notes
  • Posters
  • Workshops
  • Videos & Webinars
  • Articles

Browse by Category

  • Application
    • Diagnostic and Imaging
    • Genetic Medicine
    • Hematology
    • Metabolic Disorders
    • Neuroscience
    • Oncology
    • Skeletal Disorders
    • Targeted Drug Delivery
    • Vaccines
    • Other Applications
    • Cell therapy
  • Formulation
    • Liposomes
    • Nucleic Acid Lipid Nanoparticles
    • Polymeric Nanoparticles
    • Other Formulations
  • Payload
    • DNA
    • microRNA
    • mRNA
    • siRNA
    • Small Molecule Drugs
    • Other Payloads